ESR spectral transition by arteriovenous cycle in nitric oxide hemoglobin of cytokine-treated rats.
Nitric oxide (NO) generation was induced in rats by Escherichia coli lipopolysaccharide (LPS) as detected by electron spin resonance (ESR) signals of NO hemoglobin (HbNO). However, there were inconsistencies in ESR spectral shape among them. We have therefore carried out a systematic study to clarify the in vivo spectral changes. First, the spectra of the alpha-NO heme species had the distinct three-line hyperfine structure in venous blood but not in arterial blood in all rats treated with tumor necrosis factor, interleukin-1, and/or LPS, and methemoglobin was not detected at the g = 6 (high-spin methemoglobin) region. Second, when the treated rats died, the three-line hyperfine structure was very distinct even in arterial blood. Third, even if HbNO was formed by injection of nitrite to rats, the three-line hyperfine structure of HbNO in venous blood was more marked than that in arterial blood, independent of the appearance of the methemoglobin signal. Fourth, an ex vivo study using whole blood demonstrated that the three-line hyperfine structure intensified lineally when O2 saturation of hemoglobin decreased but disappeared on reoxygenation of hemoglobin. These results directly demonstrate in vivo quaternary structural transition of the hemoglobin tetramer from the high-affinity state in the arterial cycle to the low-affinity state in the venous cycle. The transition makes the diverse ESR spectra of HbNO in vivo.
Kosaka
H
H
Department of Physiology, Medical School, Osaka University, Japan.
Sawai
Y
Y
Sakaguchi
H
H
Kumura
E
E
Harada
N
N
Watanabe
M
M
Shiga
T
T
D000818:Animals; D001158:Arteries / Q000502:physiology; D001775:Blood Circulation; D004578:Electron Spin Resonance Spectroscopy / Q000379:methods; D004926:Escherichia coli; D006442:Glycated Hemoglobin / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000633:toxicity; D008297:Male; D009569:Nitric Oxide / Q000737:chemistry / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D014680:Veins / Q000502:physiology
D006442:Glycated Hemoglobin; D007375:Interleukin-1; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; C058377:hemoglobin A, glycosylated-nitric oxide complex